Biofrontera AG (FRA:B8FK)

Biofrontera AG Statistics

Total Valuation

Biofrontera AG has a market cap or net worth of EUR 15.50 million. The enterprise value is 12.57 million.

Market Cap	15.50M
Enterprise Value	12.57M

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	6.08M
Shares Outstanding	n/a
Shares Change (YoY)	+104.99%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	7.20%
Float	1.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.67
PB Ratio	1.05
P/TBV Ratio	1.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.88
EV / Sales	0.54
EV / EBITDA	41.39
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.04.

Current Ratio	2.91
Quick Ratio	1.13
Debt / Equity	0.04
Debt / EBITDA	1.21
Debt / FCF	n/a
Interest Coverage	-33.00

Financial Efficiency

Return on equity (ROE) is -13.47% and return on invested capital (ROIC) is -1.00%.

Return on Equity (ROE)	-13.47%
Return on Assets (ROA)	-0.77%
Return on Invested Capital (ROIC)	-1.00%
Return on Capital Employed (ROCE)	-1.78%
Revenue Per Employee	306,013
Profits Per Employee	-28,145
Employee Count	88
Asset Turnover	1.09
Inventory Turnover	1.20

Taxes

In the past 12 months, Biofrontera AG has paid 2.79 million in taxes.

Income Tax	2.79M
Effective Tax Rate	431.11%

Stock Price Statistics

The stock price has increased by +8.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.39%
50-Day Moving Average	2.55
200-Day Moving Average	2.48
Relative Strength Index (RSI)	44.87
Average Volume (20 Days)	216

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biofrontera AG had revenue of EUR 23.26 million and -2.14 million in losses. Loss per share was -0.36.

Revenue	23.26M
Gross Profit	17.91M
Operating Income	-264,000
Pretax Income	646,000
Net Income	-2.14M
EBITDA	-250
EBIT	-264,000
Loss Per Share	-0.36

Balance Sheet

The company has 3.46 million in cash and 536,000 in debt, with a net cash position of 2.92 million.

Cash & Cash Equivalents	3.46M
Total Debt	536,000
Net Cash	2.92M
Net Cash Per Share	n/a
Equity (Book Value)	14.80M
Book Value Per Share	2.44
Working Capital	9.54M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 77.00%, with operating and profit margins of -1.14% and -9.20%.

Gross Margin	77.00%
Operating Margin	-1.14%
Pretax Margin	2.78%
Profit Margin	-9.20%
EBITDA Margin	-0.00%
EBIT Margin	-1.14%
FCF Margin	n/a

Dividends & Yields

Biofrontera AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-104.99%
Shareholder Yield	-104.99%
Earnings Yield	-13.80%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 14, 2024. It was a reverse split with a ratio of 0.047619.

Last Split Date	May 14, 2024
Split Type	Reverse
Split Ratio	0.047619

Scores

Biofrontera AG has an Altman Z-Score of -5.55 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.55
Piotroski F-Score	3